LIFEARC
12Patents
12Active
12Granted
46Portfolio score
Filing activity: May 24, 2013 → Dec 14, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10669284B2 | Fused thiazolopyrimidine derivatives as MNKS inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10918645B2 | Substituted tricyclic heterocyclic compounds and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11446351B2 | Composition for treating one or more estrogen related diseases | Human Necessities | 0 | Active |
| US10961233B2 | Oxazole derivatives for use in the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US11136338B2 | Fused thiazolopyrimidine derivatives as MNKs inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10961234B2 | Oxazole derivatives for use in the treatment of cancer | Human Necessities | 0 | Active |
| US11718686B2 | Anti-transglutaminase 2 antibodies | Chemistry; Metallurgy | 0 | Active |
| US10005846B2 | Anti-transglutaminase 2 antibodies | Chemistry; Metallurgy | 0 | Active |
| US10961319B2 | Anti-transglutaminase 2 antibodies | Chemistry; Metallurgy | 0 | Active |
| US10604524B2 | Pyrropyrimidine compounds as MNKs inhibitors | Human Necessities | 0 | Active |
| US12297261B2 | Humanised anti-n-truncated amyloid β monoclonal antibody | Chemistry; Metallurgy | 0 | Active |
| US12202903B2 | Humanised anti-IL17BR antibody | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.